Aspirin Hydrolysis and Atropine Stability in Hospital Stock
A hospital pharmacy is reviewing a 24-month-old stock of 300-mg aspirin tablets and a 1% aqueous atropine sulfate eye drop. The aspirin bottles have a vinegar odor. A validated assay finds 12.4% salicylic acid in the tablets; the specification is not more than 3%. The atropine drops, stored at pH 6.8, show 2% tropic acid after 18 months, within specification. Stability data supplied by the manufacturer show that aspirin hydrolysis is first-order and has a pH-rate minimum near pH 2.5; the rate at pH 7.4 is about 100 times the rate at pH 2.5. Atropine is an ester of tropine and tropic acid; its hydrolysis is also first-order but is markedly slower at the same pH, and its rate increases steeply above pH 7. The pharmacy must decide whether to extend the aspirin expiry, reformulate the atropine drops, or change storage. The analytical chemist also reports a new infrared band at about 1670 cm−1 in the aspirin tablets and a broad band at 2500–3300 cm−1.
1. Identify the degradation reaction and products for aspirin. Using the pH-rate data, explain why an enteric-coated tablet may reduce gastric irritation but does not necessarily prevent hydrolysis during storage. What storage change would you recommend?
Read the worked answer
Aspirin is acetylsalicylic acid, an acetyl ester of salicylic acid. Hydrolysis cleaves the acetyl ester, producing salicylic acid and acetic acid; the acetic acid explains the vinegar odor. The assay's 12.4% salicylic acid exceeds the 3% limit, so this batch should not be released and its expiry should not be extended. The pH-rate profile matters because hydrolysis is both acid- and base-catalyzed, with a minimum near pH 2.5. At pH 7.4 the rate is about 100-fold higher, so an enteric coating does not make the molecule intrinsically stable. The coating is designed to remain intact in the acidic stomach and dissolve in the more alkaline intestine; it reduces gastric mucosal exposure to salicylic acid, but once the tablet is in a humid environment or the coating is damaged, hydrolysis proceeds. For storage, keep the product dry, cool, and in a tightly closed container with a desiccant, and avoid alkaline excipients. The pharmacy should reject the batch, not re-label it.
2. The IR shows a new band at 1670 cm−1 and broad absorption at 2500–3300 cm−1. Assign these features and explain why they support the assay. What other technique would distinguish salicylic acid from acetic acid?
Read the worked answer
The new band near 1670 cm−1 is consistent with the carbonyl stretch of a carboxylic acid, as in salicylic acid; aspirin's ester carbonyl typically appears at higher wavenumber (about 1750 cm−1), while its carboxylic acid carbonyl is near 1690 cm−1. The broad 2500–3300 cm−1 absorption is the hydrogen-bonded O–H stretch of a carboxylic acid. Together these features support accumulation of salicylic acid, but IR alone is not specific: acetic acid also has a carboxylic acid O–H and a C=O, although its C=O is nearer 1710 cm−1. A better discriminator is 1H NMR. Salicylic acid lacks the acetyl methyl singlet at about 2.3 ppm that is present in aspirin; it shows aromatic protons and a carboxylic acid proton. Acetic acid would show a methyl singlet near 2.1 ppm. HPLC with a salicylic acid standard is the practical confirmatory assay and can quantify the 12.4% finding. The IR data are therefore supportive, not definitive.
3. Atropine drops at pH 6.8 show only 2% tropic acid after 18 months, while aspirin at similar pH would be much more degraded. Explain the difference in terms of structure and mechanism, and decide whether the atropine formulation should be changed. What pH would you choose?
Read the worked answer
Atropine is tropine tropate, an ester formed from tropine and tropic acid. Its hydrolysis yields tropine and tropic acid, the latter being the degradant measured. The ester carbonyl is flanked by the bulky tropine ring and the phenyl-substituted tropic acid carbon, so nucleophilic attack and the transition state are sterically hindered. Aspirin's acetyl ester is much less hindered, and its nearby carboxylate can participate in intramolecular general base catalysis, accelerating hydrolysis. That is why atropine can retain 98% after 18 months at pH 6.8 while aspirin at a similar pH would degrade much faster. The atropine result is within a typical specification, so routine reformulation is not automatically required. If a change is made for stability, a mildly acidic pH (roughly 5–6) would reduce ester hydrolysis, but lowering pH increases the fraction of protonated atropine and can reduce corneal penetration and comfort. The decision should be based on the specification, the route of administration, and a stability-indicating assay, not on pH alone.